{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:31:29Z","timestamp":1766467889157},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.transci.2016.07.019","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T15:53:21Z","timestamp":1469202801000},"page":"225-232","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety and efficacy of the leukocytapheresis procedure in eighty-five patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"55","author":[{"given":"Mie","family":"Kitagaichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makio","family":"Kusaoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Kon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kempe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2016.07.019_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0065-2776(08)60299-0","article-title":"The immunopathology of joint inflammation in rheumatoid arthritis","volume":"16","author":"Zvaifler","year":"1973","journal-title":"Adv Immunol"},{"key":"10.1016\/j.transci.2016.07.019_bib0015","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of non-biologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2016.07.019_bib0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transci.2016.07.019_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.transci.2016.07.019_bib0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1440-1746.2012.07119.x","article-title":"Current status and future perspectives of leucocytapheresis for inflammatory bowel disease","volume":"27","author":"Fukunaga","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/1529-0131(199904)42:3<431::AID-ANR6>3.0.CO;2-2","article-title":"Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Hidaka","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2016.07.019_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/rheumatology\/39.2.165","article-title":"Evaluation of filtration leukocytapheresis for use in the treatment of patients with rheumatoid arthritis","volume":"39","author":"Ueki","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.transci.2016.07.019_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1526-0968.2004.00132.x","article-title":"Leukocytapheresis and Methotrexate for RA","volume":"8","author":"Kempe","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2016.07.019_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/s10165-005-0448-0","article-title":"Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis","volume":"16","author":"Izumi","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1744-9987.2006.00403.x","article-title":"Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis","volume":"10","author":"Onuma","year":"2006","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2016.07.019_bib0060","first-page":"810","article-title":"A multicenter study of leukocytapheresis in rheumatoid arthritis","volume":"25","author":"Ueki","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/s10165-007-0630-7","article-title":"Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis","volume":"17","author":"Eguchi","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5414\/CNP68121","article-title":"Leukocytapheresis (LCAP) for the treatment of rheumatoid arthritis on a maintenance hemodialysis patient","volume":"68","author":"Ohsawa","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.transci.2016.07.019_bib0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/s10165-007-0576-9","article-title":"Improved response to infliximab after leukocytapheresis in a patient with rheumatoid arthritis","volume":"17","author":"Azuma","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2177\/jsci.32.499","article-title":"Investigation of the clinical usefulness of leukocytapheresis on rheumatoid arthritis resistant to or failed with the other treatments","volume":"32","author":"Sawada","year":"2009","journal-title":"Jpn. J. Clin. Immunol"},{"key":"10.1016\/j.transci.2016.07.019_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1744-9987.2009.00657.x","article-title":"Efficacy of high-throughput leukocytapheresis for rheumatoid arthritis with a reduced response to infliximab","volume":"13","author":"Sakai","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2016.07.019_bib0090","first-page":"44","article-title":"Clinical efficacy of leukocytapheresis in rheumatoid arthritis","volume":"28","author":"Onuma","year":"2009","journal-title":"Jpn J Apher"},{"key":"10.1016\/j.transci.2016.07.019_bib0095","doi-asserted-by":"crossref","first-page":"806","DOI":"10.5035\/nishiseisai.59.806","article-title":"Leukocytapheresis therapy in rheumatoid arthritis","volume":"59","author":"Urakawa","year":"2010","journal-title":"Orthop Traumatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/14397595.2013.874752","article-title":"Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis","volume":"25","author":"Maeshima","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0105","first-page":"255","article-title":"Leukocytapheresis therapy in rheumatoid arthritis in our hospital","volume":"25","author":"Hidaka","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1526-0968.2002.00459.x","article-title":"Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers","volume":"6","author":"Yamaji","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2016.07.019_bib0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2177\/jsci.34.447","article-title":"The mechanism of the efficiency of leukocytaheresis on rheumatoid arthritis","volume":"34","author":"Hidaka","year":"2011","journal-title":"Jpn J Clin Immunol"},{"key":"10.1016\/j.transci.2016.07.019_bib0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1526-0968.1999.00136.x","article-title":"Changes in CD4+T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis","volume":"3","author":"Hidaka","year":"1999","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2016.07.019_bib0125","first-page":"256","article-title":"Current status and future of CAP therapy","volume":"15","author":"Yokoyama","year":"2011","journal-title":"Intestine"},{"key":"10.1016\/j.transci.2016.07.019_bib0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/s10165-009-0164-2","article-title":"Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritis","volume":"19","author":"Umekita","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.transci.2016.07.019_bib0135","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/art.1780240701","article-title":"Lymphapheresis in rheumatoid arthritis. A randomized trial","volume":"24","author":"Karsh","year":"1981","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.transci.2016.07.019_bib0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/s10165-008-0045-0","article-title":"Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study","volume":"18","author":"Miyasaka","year":"2008","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.transci.2016.07.019_bib0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/s10165-008-0125-1","volume":"19","author":"Nishimoto","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.transci.2016.07.019_bib0150","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/14397595.2014.995875","article-title":"Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study","volume":"25","author":"Tanaka","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.transci.2016.07.019_bib0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/14397595.2015.1074648","article-title":"Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: results from a randomized phase II trial","volume":"26","author":"Takeuchi","year":"2016","journal-title":"Mod Rheumatol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216300878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216300878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:20:30Z","timestamp":1536571230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050216300878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1473050216300878"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2016.07.019","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of the leukocytapheresis procedure in eighty-five patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2016.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}